Prilosec OTC Part Of “Engine Of Growth” P&G Expects From Health Care Sales
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble's Prilosec OTC (omeprazole) reached nearly 40 percent market share in the firm's latest quarter to lead the OTC heartburn medication segment
You may also be interested in...
Vicks Nears $1 Bil. In Sales Under “Focused” Growth Strategy – P&G
The Vicks brand of over-the-counter cough, cold and flu products is "on its way" to becoming a $1 billion franchise, according to Procter & Gamble President and CEO A.G. Lafley
Vicks Nears $1 Bil. In Sales Under “Focused” Growth Strategy – P&G
The Vicks brand of over-the-counter cough, cold and flu products is "on its way" to becoming a $1 billion franchise, according to Procter & Gamble President and CEO A.G. Lafley
Vicks Nears $1 Bil. In Sales Under “Focused” Growth Strategy – P&G
The Vicks brand of over-the-counter cough, cold and flu products is "on its way" to becoming a $1 billion franchise, according to Procter & Gamble President and CEO A.G. Lafley